Genetics of panic disorder: focus on association studies and therapeutic perspectives

References

• Grant BF, Stinson FS, Dawson DA et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry61(8), 807–816 (2004).
   PubMed Web of Science ®Google Scholar
• Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry62(6), 593–602 (2005).
   PubMed Web of Science ®Google Scholar
• Weissman MM, Bland RC, Canino GJ et al. The cross-national epidemiology of panic disorder. Arch. Gen. Psychiatry54(4), 305–309 (1997).
   PubMed Web of Science ®Google Scholar
• Wittchen HU, Reed V, Kessler RC. The relationship of agoraphobia and panic in a community sample of adolescents and young adults. Arch. Gen. Psychiatry55(11), 1017–1024 (1998).
   PubMedGoogle Scholar
• Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry63(4), 415–424 (2006).
   PubMed Web of Science ®Google Scholar
• Horesh N, Amir M, Kedem P, Goldberger Y, Kotler M. Life events in childhood, adolescence and adulthood and the relationship to panic disorder. Acta Psychiatr. Scand.96(5), 373–378 (1997).
   Google Scholar
• Faravelli C, Pallanti S. Recent life events and panic disorder. Am. J. Psychiatry146(5), 622–626 (1989).
   PubMed Web of Science ®Google Scholar
• Fyer AJ, Katon W, Hollifield M et al. The DSM-IV panic disorder field trial: panic attack frequency and functional disability. Anxiety2(4), 157–166 (1996).
   Google Scholar
• Horwath E, Wolk SI, Goldstein RB et al. Is the comorbidity between social phobia and panic disorder due to familial cotransmission or other factors? Arch. Gen. Psychiatry52(7), 574–582 (1995).
   Google Scholar
• Maier W, Lichtermann D, Minges J, Oehrlein A, Franke P. A controlled family study in panic disorder. J. Psychiatr. Res.27(Suppl. 1), 79–87 (1993).
   Google Scholar
• Mendlewicz J, Papadimitriou GN, Wilmotte J. Family study of panic disorder: comparison with generalized anxiety disorder, major depression and normal subjects. Psychiatr. Genet.3, 73–78 (1993).
   Google Scholar
• Mendlewicz J, Sevy S, Mendelbaum K. Minireview: molecular genetics in affective illness. Life Sci.52(3), 231–242 (1993).
   Google Scholar
• Noyes R Jr, Crowe RR, Harris EL, Hamra BJ, McChesney CM, Chaudhry DR. Relationship between panic disorder and agoraphobia. A family study. Arch. Gen. Psychiatry43(3), 227–232 (1986).
   PubMed Web of Science ®Google Scholar
• Goldstein RB, Weissman MM, Adams PB et al. Psychiatric disorders in relatives of probands with panic disorder and/or major depression. Arch. Gen. Psychiatry51(5), 383–394 (1994).
   PubMed Web of Science ®Google Scholar
• Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am. J. Psychiatry158(10), 1568–1578 (2001).
   PubMed Web of Science ®Google Scholar
• Goldstein RB, Wickramaratne PJ, Horwath E, Weissman MM. Familial aggregation and phenomenology of ‘early’-onset (at or before age 20 years) panic disorder. Arch. Gen. Psychiatry54(3), 271–278 (1997).
   PubMed Web of Science ®Google Scholar
• Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. Panic disorder in women: a population-based twin study. Psychol. Med.23(2), 397–406 (1993).
   PubMed Web of Science ®Google Scholar
• Hettema JM, Prescott CA, Myers JM, Neale MC, Kendler KS. The structure of genetic and environmental risk factors for anxiety disorders in men and women. Arch. Gen. Psychiatry62(2), 182–189 (2005).
   PubMed Web of Science ®Google Scholar
• Vieland VJ, Goodman DW, Chapman T, Fyer AJ. New segregation analysis of panic disorder. Am. J. Med. Genet.67(2), 147–153 (1996).
   PubMed Web of Science ®Google Scholar
• Lander ES, Schork NJ. Genetic dissection of complex traits. Science265(5181), 2037–2048 (1994).
   PubMed Web of Science ®Google Scholar
• Crowe RR, Noyes R Jr, Wilson AF, Elston RC, Ward LJ. A linkage study of panic disorder. Arch. Gen. Psychiatry44(11), 933–937 (1987).
   Google Scholar
• Knowles JA, Fyer AJ, Vieland VJ et al. Results of a genome-wide genetic screen for panic disorder. Am. J. Med. Genet.81(2), 139–147 (1998).
   Google Scholar
• Crowe RR, Goedken R, Samuelson S, Wilson R, Nelson J, Noyes R Jr. Genomewide survey of panic disorder. Am. J. Med. Genet.105(1), 105–109 (2001).
   PubMed Web of Science ®Google Scholar
• Meyer AH, Ullmer C, Schmuck K et al. Localization of the human CRF2 receptor to 7p21-p15 by radiation hybrid mapping and FISH analysis. Genomics40(1), 189–190 (1997).
   PubMedGoogle Scholar
• Hamilton SP, Fyer AJ, Durner M et al. Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q. Proc. Natl Acad. Sci. USA100(5), 2550–2555 (2003).
   Google Scholar
• Fyer AJ, Hamilton SP, Durner M et al. A third-pass genome scan in panic disorder: evidence for multiple susceptibility loci. Biol. Psychiatry60(4), 388–401 (2006).
   PubMed Web of Science ®Google Scholar
• Gelernter J, Bonvicini K, Page G et al. Linkage genome scan for loci predisposing to panic disorder or agoraphobia. Am. J. Med. Genet.105(6), 548–557 (2001).
   Google Scholar
• Kaabi B, Gelernter J, Woods SW, Goddard A, Page GP, Elston RC. Genome scan for loci predisposing to anxiety disorders using a novel multivariate approach: strong evidence for a chromosome 4 risk locus. Am. J. Hum. Genet.78(4), 543–553 (2006).
   Google Scholar
• Tebbe JJ, Tebbe CG, Mronga S, Ritter M, Schafer MK. Central neuropeptide Y receptors are involved in 3rd ventricular ghrelin induced alteration of colonic transit time in conscious fed rats. BMC Gastroenterol.5, 5 (2005).
   PubMedGoogle Scholar
• Smoller JW, Acierno JS Jr, Rosenbaum JF et al. Targeted genome screen of panic disorder and anxiety disorder proneness using homology to murine QTL regions. Am. J. Med. Genet.105(2), 195–206 (2001).
   Google Scholar
• Thorgeirsson TE, Oskarsson H, Desnica N et al. Anxiety with panic disorder linked to chromosome 9q in Iceland. Am. J. Hum. Genet.72(5), 1221–1230 (2003).
   PubMed Web of Science ®Google Scholar
• Schruers K, Klaassen T, Pols H, Overbeek T, Deutz NE, Griez E. Effects of tryptophan depletion on carbon dioxide provoked panic in panic disorder patients. Psychiatry Res.93(3), 179–187 (2000).
   PubMed Web of Science ®Google Scholar
• Schruers K, van Diest R, Overbeek T, Griez E. Acute L-5-hydroxytryptophan administration inhibits carbon dioxide-induced panic in panic disorder patients. Psychiatry Res.113(3), 237–243 (2002).
   PubMed Web of Science ®Google Scholar
• Nash JR, Sargent PA, Rabiner EA et al. Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study. Br. J. Psychiatry193(3), 229–234 (2008).
   PubMed Web of Science ®Google Scholar
• Bakker A, van Balkom AJ, Stein DJ. Evidence-based pharmacotherapy of panic disorder. Int. J. Neuropsychopharmacol.8(3), 473–482 (2005).
   PubMed Web of Science ®Google Scholar
• Invernizzi RW. Role of TPH-2 in brain function: news from behavioral and pharmacologic studies. J. Neurosci. Res.85(14), 3030–3035 (2007).
   Google Scholar
• Fehr C, Schleicher A, Szegedi A et al. Serotonergic polymorphisms in patients suffering from alcoholism, anxiety disorders and narcolepsy. Prog. Neuropsychopharmacol. Biol. Psychiatry25(5), 965–982 (2001).
   PubMedGoogle Scholar
• Han L, Nielsen DA, Rosenthal NE et al. No coding variant of the tryptophan hydroxylase gene detected in seasonal affective disorder, obsessive–compulsive disorder, anorexia nervosa, and alcoholism. Biol. Psychiatry45(5), 615–619 (1999).
   PubMed Web of Science ®Google Scholar
• Kim W, Choi YH, Yoon KS, Cho DY, Pae CU, Woo JM. Tryptophan hydroxylase and serotonin transporter gene polymorphism does not affect the diagnosis, clinical features and treatment outcome of panic disorder in the Korean population. Prog. Neuropsychopharmacol. Biol. Psychiatry30(8), 1413–1418 (2006).
   PubMed Web of Science ®Google Scholar
• Maron E, Lang A, Tasa G et al. Associations between serotonin-related gene polymorphisms and panic disorder. Int. J. Neuropsychopharmacol.8(2), 261–266 (2005).
   PubMed Web of Science ®Google Scholar
• Yoon HK, Yang JC, Lee HJ, Kim YK. The association between serotonin-related gene polymorphisms and panic disorder. J. Anxiety Disord.22(8), 1529–1534 (2008).
   PubMed Web of Science ®Google Scholar
• Mossner R, Freitag CM, Gutknecht L et al. The novel brain-specific tryptophan hydroxylase-2 gene in panic disorder. J. Psychopharmacol.20(4), 547–552 (2006).
   PubMedGoogle Scholar
• Kim YK, Lee HJ, Yang JC, Hwang JA, Yoon HK. A tryptophan hydroxylase 2 gene polymorphism is associated with panic disorder. Behav. Genet.39(2), 170–175 (2009).
   PubMedGoogle Scholar
• Maron E, Toru I, Must A et al. Association study of tryptophan hydroxylase 2 gene polymorphisms in panic disorder. Neurosci. Lett.411(3), 180–184 (2007).
   PubMed Web of Science ®Google Scholar
• Albert PR, Lemonde S. 5-HT1A receptors, gene repression, and depression: guilt by association. Neuroscientist10(6), 575–593 (2004).
   PubMed Web of Science ®Google Scholar
• Kent JM, Mathew SJ, Gorman JM. Molecular targets in the treatment of anxiety. Biol. Psychiatry52(10), 1008–1030 (2002).
   PubMed Web of Science ®Google Scholar
• Lemonde S, Turecki G, Bakish D et al. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J. Neurosci.23(25), 8788–8799 (2003).
   PubMed Web of Science ®Google Scholar
• Rothe C, Gutknecht L, Freitag C et al. Association of a functional 1019C>G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia. Int. J. Neuropsychopharmacol.7(2), 189–192 (2004).
   PubMed Web of Science ®Google Scholar
• Huang YY, Battistuzzi C, Oquendo MA et al. Human 5-HT1A receptor C(-1019)G polymorphism and psychopathology. Int. J. Neuropsychopharmacol.7(4), 441–451 (2004).
   PubMed Web of Science ®Google Scholar
• Strug LJ, Suresh R, Fyer AJ et al. Panic disorder is associated with the serotonin transporter gene (SLC6A4) but not the promoter region (5-HTTLPR). Mol. Psychiatry15(2), 166–176 (2010).
   PubMed Web of Science ®Google Scholar
• Hettema JM, An SS, van den Oord EJ, Neale MC, Kendler KS, Chen X. Association study between the serotonin 1A receptor (HTR1A) gene and neuroticism, major depression, and anxiety disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(5), 661–666 (2008).
   Google Scholar
• Inada Y, Yoneda H, Koh J et al. Positive association between panic disorder and polymorphism of the serotonin 2A receptor gene. Psychiatry Res.118(1), 25–31 (2003).
   Google Scholar
• Bondy B, Spaeth M, Offenbaecher M et al. The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. Neurobiol. Dis.6(5), 433–439 (1999).
   PubMed Web of Science ®Google Scholar
• Arranz MJ, Munro J, Owen MJ et al. Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine. Mol. Psychiatry3(1), 61–66 (1998).
   PubMed Web of Science ®Google Scholar
• Maron E, Nikopensius T, Koks S et al. Association study of 90 candidate gene polymorphisms in panic disorder. Psychiatr. Genet.15(1), 17–24 (2005).
   Web of Science ®Google Scholar
• Martinez-Barrondo S, Saiz PA, Morales B et al. Serotonin gene polymorphisms in patients with panic disorder. Actas Esp. Psiquiatr.33(4), 210–215 (2005).
   PubMed Web of Science ®Google Scholar
• Unschuld PG, Ising M, Erhardt A et al. Polymorphisms in the serotonin receptor gene HTR2A are associated with quantitative traits in panic disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.144B(4), 424–429 (2007).
   PubMed Web of Science ®Google Scholar
• Deckert J, Meyer J, Catalano M et al. Novel 5´-regulatory region polymorphisms of the 5-HT2C receptor gene: association study with panic disorder. Int. J. Neuropsychopharmacol.3(4), 321–325 (2000).
   Google Scholar
• Mizuta N, Akiyoshi J, Sato A et al. Serotonin receptor 3A (HTR3A) gene is associated with personality traits, but not panic disorder. Psychiatr. Genet.18(1), 44 (2008).
   Google Scholar
• Lesch KP, Bengel D, Heils A et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science274(5292), 1527–1531 (1996).
   PubMed Web of Science ®Google Scholar
• Ishiguro H, Arinami T, Yamada K, Otsuka Y, Toru M, Shibuya H. An association study between a transcriptional polymorphism in the serotonin transporter gene and panic disorder in a Japanese population. Psychiatry Clin. Neurosci.51(5), 333–335 (1997).
   PubMed Web of Science ®Google Scholar
• Deckert J, Catalano M, Heils A et al. Functional promoter polymorphism of the human serotonin transporter: lack of association with panic disorder. Psychiatr. Genet.7(1), 45–47 (1997).
   PubMed Web of Science ®Google Scholar
• Hamilton SP, Heiman GA, Haghighi F et al. Lack of genetic linkage or association between a functional serotonin transporter polymorphism and panic disorder. Psychiatr. Genet.9(1), 1–6 (1999).
   Google Scholar
• Blaya C, Salum GA, Lima MS, Leistner-Segal S, Manfro GG. Lack of association between the serotonin transporter promoter polymorphism (5-HTTLPR) and panic disorder: a systematic review and meta-analysis. Behav. Brain Funct.3, 41 (2007).
   PubMed Web of Science ®Google Scholar
• Lonsdorf TB, Ruck C, Bergstrom J et al. The symptomatic profile of panic disorder is shaped by the 5-HTTLPR polymorphism. Prog. Neuropsychopharmacol. Biol. Psychiatry33(8), 1479–1483 (2009).
   PubMed Web of Science ®Google Scholar
• Gyawali S, Subaran R, Weissman MM et al. Association of a polyadenylation polymorphism in the serotonin transporter and panic disorder. Biol. Psychiatry67(4), 331–338 (2010).
   PubMed Web of Science ®Google Scholar
• Sabol SZ, Hu S, Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum. Genet.103(3), 273–279 (1998).
   PubMed Web of Science ®Google Scholar
• Deckert J, Catalano M, Syagailo YV et al. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum. Mol. Genet.8(4), 621–624 (1999).
   PubMed Web of Science ®Google Scholar
• Jonsson EG, Norton N, Forslund K et al. Association between a promoter variant in the monoamine oxidase A gene and schizophrenia. Schizophr. Res.61(1), 31–37 (2003).
   Google Scholar
• Samochowiec J, Hajduk A, Samochowiec A et al. Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum. Psychiatry Res.128(1), 21–26 (2004).
   PubMed Web of Science ®Google Scholar
• Hamilton SP, Slager SL, Heiman GA et al. No genetic linkage or association between a functional promoter polymorphism in the monoamine oxidase-A gene and panic disorder. Mol. Psychiatry5(5), 465–466 (2000).
   Google Scholar
• Bremner JD, Krystal JH, Southwick SM, Charney DS. Noradrenergic mechanisms in stress and anxiety: II. Clinical studies. Synapse23(1), 39–51 (1996).
   PubMed Web of Science ®Google Scholar
• Redmond DE Jr, Huang YH. Current concepts. II. New evidence for a locus coeruleus–norepinephrine connection with anxiety. Life Sci.25(26), 2149–2162 (1979).
   PubMed Web of Science ®Google Scholar
• Charney DS, Heninger GR, Breier A. Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch. Gen. Psychiatry41(8), 751–763 (1984).
   PubMedGoogle Scholar
• Shulman R, Griffiths J, Diewold P. Catechol-O-methyl transferase activity in patients with depressive illness and anxiety states. Br. J. Psychiatry132, 133–138 (1978).
   Google Scholar
• Richard IH, Schiffer RB, Kurlan R. Anxiety and Parkinson’s disease. J. Neuropsychiatry Clin. Neurosci.8(4), 383–392 (1996).
   PubMed Web of Science ®Google Scholar
• Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics6(3), 243–250 (1996).
   PubMedGoogle Scholar
• Hamilton SP, Slager SL, Heiman GA et al. Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22. Biol. Psychiatry51(7), 591–601 (2002).
   PubMed Web of Science ®Google Scholar
• Domschke K, Freitag CM, Kuhlenbaumer G et al. Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women. Int. J. Neuropsychopharmacol.7(2), 183–188 (2004).
   PubMed Web of Science ®Google Scholar
• Rothe C, Koszycki D, Bradwejn J et al. Association of the Val158Met catechol O-methyltransferase genetic polymorphism with panic disorder. Neuropsychopharmacology31(10), 2237–2242 (2006).
   PubMed Web of Science ®Google Scholar
• Woo JM, Yoon KS, Yu BH. Catechol O-methyltransferase genetic polymorphism in panic disorder. Am. J. Psychiatry159(10), 1785–1787 (2002).
   PubMed Web of Science ®Google Scholar
• Woo JM, Yoon KS, Choi YH, Oh KS, Lee YS, Yu BH. The association between panic disorder and the L/L genotype of catechol-O-methyltransferase. J. Psychiatr. Res.38(4), 365–370 (2004).
   PubMed Web of Science ®Google Scholar
• Ohara K, Nagai M, Suzuki Y, Ochiai M. No association between anxiety disorders and catechol-O-methyltransferase polymorphism. Psychiatry Res.80(2), 145–148 (1998).
   PubMed Web of Science ®Google Scholar
• Gogos JA, Morgan M, Luine V et al. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc. Natl Acad. Sci. USA95(17), 9991–9996 (1998).
   PubMed Web of Science ®Google Scholar
• Domschke K, Deckert J, O’Donovan MC, Glatt SJ. Meta-analysis of COMT val158met in panic disorder: ethnic heterogeneity and gender specificity. Am. J. Med. Genet. B Neuropsychiatr. Genet.144B(5), 667–673 (2007).
   Google Scholar
• Sand PG, Mori T, Godau C et al. Norepinephrine transporter gene (NET) variants in patients with panic disorder. Neurosci. Lett.333(1), 41–44 (2002).
   PubMed Web of Science ®Google Scholar
• Lee YJ, Hohoff C, Domschke K et al. Norepinephrine transporter (NET) promoter and 5´-UTR polymorphisms: association analysis in panic disorder. Neurosci. Lett.377(1), 40–43 (2005).
   PubMed Web of Science ®Google Scholar
• Hettema JM, An SS, Neale MC et al. Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism. Mol. Psychiatry11(8), 752–762 (2006).
   PubMed Web of Science ®Google Scholar
• Rupprecht R, Zwanzger P. Significance of GABAA receptors for the pathophysiology and therapy of panic disorders. Nervenarzt74(7), 543–551 (2003).
   Google Scholar
• Crowe RR, Wang Z, Noyes R Jr et al. Candidate gene study of eight GABAA receptor subunits in panic disorder. Am. J. Psychiatry154(8), 1096–1100 (1997).
   Google Scholar
• Kobayashi Y, Akiyoshi J, Kanehisa M et al. Lack of polymorphism in genes encoding mGluR 7, mGluR 8, GABAA receptor α-6 subunit and nociceptin/orphanin FQ receptor and panic disorder. Psychiatr. Genet.17(1), 9 (2007).
   PubMed Web of Science ®Google Scholar
• Sand PG, Godau C, Riederer P et al. Exonic variants of the GABAB receptor gene and panic disorder. Psychiatr. Genet.10(4), 191–194 (2000).
   PubMed Web of Science ®Google Scholar
• Thoeringer CK, Binder EB, Salyakina D et al. Association of a Met88Val diazepam binding inhibitor (DBI) gene polymorphism and anxiety disorders with panic attacks. J. Psychiatr. Res.41(7), 579–584 (2007).
   Google Scholar
• Zwanzger P, Rupprecht R. Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder. J. Psychiatry Neurosci.30(3), 167–175 (2005).
   PubMed Web of Science ®Google Scholar
• Thoeringer CK, Ripke S, Unschuld PG et al. The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disorders. J. Neural Transm.116(6), 649–657 (2009).
   PubMed Web of Science ®Google Scholar
• Moreau JL, Huber G. Central adenosine A2A receptors: an overview. Brain Res. Brain Res. Rev.31(1), 65–82 (1999).
   PubMed Web of Science ®Google Scholar
• Guieu R, Dussol B, Halimi G et al. Adenosine and the nervous system: pharmacological data and therapeutic perspectives. Gen. Pharmacol.31(4), 553–561 (1998).
   Google Scholar
• Lee MA, Flegel P, Greden JF, Cameron OG. Anxiogenic effects of caffeine on panic and depressed patients. Am. J. Psychiatry145(5), 632–635 (1988).
   PubMedGoogle Scholar
• Nickell PV, Uhde TW. Dose–response effects of intravenous caffeine in normal volunteers. Anxiety1(4), 161–168 (1994).
   PubMedGoogle Scholar
• Deckert J, Nothen MM, Franke P et al. Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol. Psychiatry3(1), 81–85 (1998).
   PubMed Web of Science ®Google Scholar
• Hamilton SP, Slager SL, De Leon AB et al. Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder. Neuropsychopharmacology29(3), 558–565 (2004).
   PubMed Web of Science ®Google Scholar
• Yamada K, Hattori E, Shimizu M, Sugaya A, Shibuya H, Yoshikawa T. Association studies of the cholecystokinin B receptor and A2a adenosine receptor genes in panic disorder. J. Neural Transm.108(7), 837–848 (2001).
   Google Scholar
• Lam P, Hong CJ, Tsai SJ. Association study of A2a adenosine receptor genetic polymorphism in panic disorder. Neurosci. Lett.378(2), 98–101 (2005).
   Google Scholar
• Tharmalingam S, King N, De Luca V et al. Lack of association between the corticotrophin-releasing hormone receptor 2 gene and panic disorder. Psychiatr. Genet.16(3), 93–97 (2006).
   Google Scholar
• Hodges LM, Weissman MM, Haghighi F et al. Association and linkage analysis of candidate genes GRP, GRPR, CRHR1, and TACR1 in panic disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.150B(1), 65–73 (2009).
   Google Scholar
• Unschuld PG, Ising M, Erhardt A et al. Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder. J. Affect. Disord.105(1–3), 177–184 (2008).
   Google Scholar
• Sand PG, Schlurmann K, Luckhaus C et al. Estrogen receptor 1 gene (ESR1) variants in panic disorder. Am. J. Med. Genet.114(4), 426–428 (2002).
   Google Scholar
• Ho HP, Westberg L, Annerbrink K et al. Association between a functional polymorphism in the progesterone receptor gene and panic disorder in women. Psychoneuroendocrinology29(9), 1138–1141 (2004).
   Web of Science ®Google Scholar
• Vanderhaeghen JJ, Signeau JC, Gepts W. New peptide in the vertebrate CNS reacting with antigastrin antibodies. Nature257(5527), 604–605 (1975).
   PubMed Web of Science ®Google Scholar
• Bradwejn J, Koszycki D, Shriqui C. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings. Arch. Gen. Psychiatry48(7), 603–610 (1991).
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Fukushige S, Murotsu T, Matsubara K. Structure of human cholecystokinin gene and its chromosomal location. Gene50(1–3), 353–360 (1986).
   PubMedGoogle Scholar
• Wang Z, Valdes J, Noyes R, Zoega T, Crowe RR. Possible association of a cholecystokinin promotor polymorphism (CCK-36CT) with panic disorder. Am. J. Med. Genet.81(3), 228–234 (1998).
   Google Scholar
• Hattori E, Ebihara M, Yamada K, Ohba H, Shibuya H, Yoshikawa T. Identification of a compound short tandem repeat stretch in the 5´-upstream region of the cholecystokinin gene, and its association with panic disorder but not with schizophrenia. Mol. Psychiatry6(4), 465–470 (2001).
   Google Scholar
• Hamilton SP, Slager SL, Helleby L et al. No association or linkage between polymorphisms in the genes encoding cholecystokinin and the cholecystokinin B receptor and panic disorder. Mol. Psychiatry6(1), 59–65 (2001).
   PubMed Web of Science ®Google Scholar
• Hosing VG, Schirmacher A, Kuhlenbaumer G et al. Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder. J. Neural Transm. Suppl.68, 147–156 (2004).
   PubMedGoogle Scholar
• Koefoed P, Woldbye DP, Hansen TO et al. Gene variations in the cholecystokinin system in patients with panic disorder. Psychiatr. Genet.20(2), 59–64 (2009).
   Google Scholar
• Wank SA. Cholecystokinin receptors. Am. J. Physiol.269(5 Pt 1), G628–G646 (1995).
   PubMed Web of Science ®Google Scholar
• Monnikes H, Lauer G, Arnold R. Peripheral administration of cholecystokinin activates c-fos expression in the locus coeruleus/subcoeruleus nucleus, dorsal vagal complex and paraventricular nucleus via capsaicin-sensitive vagal afferents and CCK-A receptors in the rat. Brain Res.770(1–2), 277–288 (1997).
   Google Scholar
• Huppi K, Siwarski D, Pisegna JR, Wank S. Chromosomal localization of the gastric and brain receptors for cholecystokinin (CCKAR and CCKBR) in human and mouse. Genomics25(3), 727–729 (1995).
   Google Scholar
• Miyasaka K, Yoshida Y, Matsushita S et al. Association of cholecystokinin-A receptor gene polymorphisms and panic disorder in Japanese. Am. J. Med. Genet. B Neuropsychiatr. Genet.127B(1), 78–80 (2004).
   Google Scholar
• Kennedy JL, Bradwejn J, Koszycki D et al. Investigation of cholecystokinin system genes in panic disorder. Mol. Psychiatry4(3), 284–285 (1999).
   PubMed Web of Science ®Google Scholar
• Ise K, Akiyoshi J, Horinouchi Y, Tsutsumi T, Isogawa K, Nagayama H. Association between the CCK-A receptor gene and panic disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.B118(1), 29–31 (2003).
   Google Scholar
• Song I, Brown DR, Wiltshire RN, Gantz I, Trent JM, Yamada T. The human gastrin/cholecystokinin type B receptor gene: alternative splice donor site in exon 4 generates two variant mRNAs. Proc. Natl Acad. Sci. USA90(19), 9085–9089 (1993).
   PubMed Web of Science ®Google Scholar
• Kato T, Wang ZW, Zoega T, Crowe RR. Missense mutation of the cholecystokinin B receptor gene: lack of association with panic disorder. Am. J. Med. Genet.67(4), 401–405 (1996).
   Google Scholar
• Domschke K, Hohoff C, Jacob C et al. Chromosome 4q31–34 panic disorder risk locus: association of neuropeptide Y Y5 receptor variants. Am. J. Med. Genet. B Neuropsychiatr. Genet.B147(4), 510–516 (2008).
   Google Scholar
• Lindberg C, Koefoed P, Hansen ES et al. No association between the -399 C > T polymorphism of the neuropeptide Y gene and schizophrenia, unipolar depression or panic disorder in a Danish population. Acta Psychiatr. Scand.113(1), 54–58 (2006).
   PubMed Web of Science ®Google Scholar
• Otowa T, Shimada T, Kawamura Y et al. No association between the brain-derived neurotrophic factor gene and panic disorder in Japanese population. J. Hum. Genet.54(8), 437–439 (2009).
   PubMed Web of Science ®Google Scholar
• Shimizu E, Hashimoto K, Koizumi H et al. No association of the brain-derived neurotrophic factor (BDNF) gene polymorphisms with panic disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry29(5), 708–712 (2005).
   PubMed Web of Science ®Google Scholar
• Lam P, Cheng CY, Hong CJ, Tsai SJ. Association study of a brain-derived neurotrophic factor (Val66Met) genetic polymorphism and panic disorder. Neuropsychobiology49(4), 178–181 (2004).
   Web of Science ®Google Scholar
• Shimizu E, Hashimoto K, Kobayashi K et al. Lack of association between angiotensin I-converting enzyme insertion/deletion gene functional polymorphism and panic disorder in humans. Neurosci. Lett.363(1), 81–83 (2004).
   Google Scholar
• Bandelow B, Saleh K, Pauls J, Domschke K, Wedekind D, Falkai P. Insertion/deletion polymorphism in the gene for angiotensin converting enzyme (ACE) in panic disorder: A gender-specific effect? World J. Biol. Psychiatry10, 1–5 (2007).
   Google Scholar
• Olsson M, Annerbrink K, Westberg L et al. Angiotensin-related genes in patients with panic disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.B127(1), 81–84 (2004).
   Google Scholar
• Erhardt A, Lucae S, Kern N et al. Association of polymorphisms in the angiotensin-converting enzyme gene with syndromal panic attacks. Mol. Psychiatry13(3), 242–243 (2008).
   Google Scholar
• Freitag CM, Domschke K, Rothe C et al. Interaction of serotonergic and noradrenergic gene variants in panic disorder. Psychiatr. Genet.16(2), 59–65 (2006).
   PubMed Web of Science ®Google Scholar
• Alsene K, Deckert J, Sand P, de Wit H. Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology28(9), 1694–1702 (2003).
   PubMed Web of Science ®Google Scholar
• Childs E, Hohoff C, Deckert J, Xu K, Badner J, de Wit H. Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology33(12), 2791–2800 (2009).
   Google Scholar
• Stein MB, Schork NJ, Gelernter J. Gene-by-environment (serotonin transporter and childhood maltreatment) interaction for anxiety sensitivity, an intermediate phenotype for anxiety disorders. Neuropsychopharmacology33(2), 312–319 (2008).
   PubMed Web of Science ®Google Scholar
• Logue MW, Durner M, Heiman GA et al. A linkage search for joint panic disorder/bipolar genes. Am. J. Med. Genet. B Neuropsychiatr. Genet.B150(8), 1139–1146 (2009).
   Google Scholar
• Erhardt A, Lucae S, Unschuld PG et al. Association of polymorphisms in P2RX7 and CaMKKb with anxiety disorders. J. Affect. Disord.101(1–3), 159–168 (2007).
   Google Scholar
• Weissman MM, Fyer AJ, Haghighi F et al. Potential panic disorder syndrome: clinical and genetic linkage evidence. Am. J. Med. Genet.96(1), 24–35 (2000).
   Google Scholar
• Jacob CP, Strobel A, Hohenberger K et al. Association between allelic variation of serotonin transporter function and neuroticism in anxious cluster C personality disorders. Am. J. Psychiatry161(3), 569–572 (2004).
   PubMedGoogle Scholar
• Domschke K, Ohrmann P, Braun M et al. Influence of the catechol-O-methyltransferase val158met genotype on amygdala and prefrontal cortex emotional processing in panic disorder. Psychiatry Res.163(1), 13–20 (2008).
   PubMed Web of Science ®Google Scholar
• Cannon TD, Keller MC. Endophenotypes in the genetic analyses of mental disorders. Annu. Rev. Clin. Psychol.2, 267–290 (2006).
   PubMed Web of Science ®Google Scholar
• Nakamura M, Ueno S, Sano A, Tanabe H. Polymorphisms of the human homologue of the Drosophila white gene are associated with mood and panic disorders. Mol. Psychiatry4(2), 155–162 (1999).
   PubMed Web of Science ®Google Scholar
• Domschke K, Kuhlenbaumer G, Schirmacher A et al. Human nuclear transcription factor gene CREM: genomic organization, mutation screening, and association analysis in panic disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.B117(1), 70–78 (2003).
   Google Scholar
• Hamilton SP, Slager SL, Mayo D et al. Investigation of polymorphisms in the CREM gene in panic disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.B126(1), 111–115 (2004).
   Google Scholar
• Leygraf A, Hohoff C, Freitag C et al. Rgs 2 gene polymorphisms as modulators of anxiety in humans? J. Neural Transm.113(12), 1921–1925 (2006).
   Google Scholar
• Hohoff C, Neumann A, Domschke K et al. Association analysis of Rgs7 variants with panic disorder. J. Neural Transm.116(11), 1523–1528 (2009).
   Google Scholar
• Smoller JW, Paulus MP, Fagerness JA et al. Influence of RGS2 on anxiety-related temperament, personality, and brain function. Arch. Gen. Psychiatry65(3), 298–308 (2008).
   PubMed Web of Science ®Google Scholar
• Amstadter AB, Koenen KC, Ruggiero KJ et al. Variant in RGS2 moderates posttraumatic stress symptoms following potentially traumatic event exposure. J. Anxiety Disord.23(3), 369–373 (2009).
   Google Scholar
• Koenen KC, Amstadter AB, Ruggiero KJ et al. RGS2 and generalized anxiety disorder in an epidemiologic sample of hurricane-exposed adults. Depress. Anxiety26(4), 309–315 (2009).
   PubMed Web of Science ®Google Scholar
• Otowa T, Yoshida E, Sugaya N et al. Genome-wide association study of panic disorder in the Japanese population. J. Hum. Genet.54(2), 122–126 (2009).
   PubMed Web of Science ®Google Scholar
• Perna G, Favaron E, Di Bella D, Bussi R, Bellodi L. Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene. Neuropsychopharmacology30(12), 2230–2235 (2005).
   PubMed Web of Science ®Google Scholar
• Yevtushenko OO, Oros MM, Reynolds GP. Early response to selective serotonin reuptake inhibitors in panic disorder is associated with a functional 5-HT1A receptor gene polymorphism. J. Affect. Disord.123(1–3), 308–311 (2009).
   Google Scholar